AHPA rebuts study
This article was originally published in The Tan Sheet
Executive Summary
The American Herbal Products Association says April 25 a case report concluding a kelp supplement caused arsenic poisoning is inaccurate. The April issue of Environmental Health Perspectives links kelp to a woman with worsening hair loss, memory loss and fatigue (1"The Tan Sheet" April 16, 2007, p. 3). AHPA says the woman ignored a specific label caution and iodine overdose, not arsenic poisoning, may have been an explanation for the woman's symptoms. "The authors fail to report that the product was used at two- to 'at least' four-times the suggested amount, of potential significance due to the naturally occurring presence of iodine in kelp," AHPA says...
You may also be interested in...
ARC Association Forms To Help Industry Address Standards, Testing
A group of scientific experts have united to "meet the common needs and aspirations of the dietary supplement industry in the area of analytical science," the newly formed Analytical Research Collective announces April 13
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.